REGULATED PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 5 months ago Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution
BRIEF published on 01/06/2025 at 08:35, 1 year 5 months ago Biophytis Temporarily Suspends Trading of Shares Before Refinancing Biophytis Biotechnology Refinancing Age-related Diseases Trading Suspension
REGULATED PRESS RELEASE published on 01/06/2025 at 08:30, 1 year 5 months ago Biophytis announces temporary suspension of the listing of its shares and share warrants prior to the completion of a refinancing transaction Biophytis temporarily suspends listing of shares and share warrants prior to refinancing transaction. Trading to resume soon Biophytis Shares Refinancing Listing Suspension
BRIEF published on 12/24/2024 at 07:05, 1 year 5 months ago Biophytis to Attend 2025 JP Morgan Healthcare Conference in San Francisco Biophytis Biotechnology Investment Opportunities JP Morgan Healthcare Conference Obesity Innovation
REGULATED PRESS RELEASE published on 12/24/2024 at 07:00, 1 year 5 months ago Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference Biophytis to attend 2025 JP Morgan Healthcare Conference in San Francisco and participate in Sachs Conference and BIO@JPM Week. The company focuses on developing treatments for age-related diseases Biophytis Biotechnology Age-related Diseases San Francisco JP Morgan Healthcare Conference
BRIEF published on 12/23/2024 at 07:05, 1 year 5 months ago Biophytis Presents Obesity Program at SCWD Congress Biophytis BIO101 Obesity GLP-1 RAs Quinolia Study
REGULATED PRESS RELEASE published on 12/23/2024 at 07:00, 1 year 5 months ago Biophytis showcased the OBA program in obesity at the 17th SCWD international congress Biophytis presented the OBA program in obesity at the 17th SCWD congress, showcasing positive results of BIO101 in overweight and obese patients, supporting further clinical development Biophytis Clinical Development BIO101 Obesity OBA Program
BRIEF published on 12/02/2024 at 07:05, 1 year 6 months ago Biophytis Engages in SCWD Congress and Hosts Obesity Investor Call Biophytis Investor Call Obesity Treatment GLP-1 RA SCWD Congress
REGULATED PRESS RELEASE published on 12/02/2024 at 07:00, 1 year 6 months ago Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call Biophytis announces participation in the 17th SCWD Congress and hosting an Obesity Investor Call. Key opinion leaders to discuss GLP-1 RA therapy. Event on December 6, 2024 Biophytis Clinical Research Obesity Investor Call SCWD Congress GLP-1 RA Therapy
BRIEF published on 09/30/2024 at 23:05, 1 year 8 months ago Biophytis Reports First-Half Financial Results and Updates on Business Activities Financial Results Biophytis Clinical Trials Obesity Treatment Partnerships
Published on 06/12/2026 at 00:00, 1 hour 53 minutes ago Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 00:00, 1 hour 53 minutes ago UraniumX Closes Oversubscribed Flow-Through Private Placement
Published on 06/11/2026 at 22:55, 2 hours 58 minutes ago Gamma Resources to Hold Annual General Meeting on August 12, 2026
Published on 06/11/2026 at 22:15, 3 hours 38 minutes ago BlackBerry to Hold Annual Meeting of Shareholders on June 25, 2026
Published on 06/11/2026 at 22:05, 3 hours 48 minutes ago First Canadian Graphite to Present at Planet MicroCap
Published on 06/11/2026 at 22:15, 3 hours 38 minutes ago HHLA Annual General Meeting resolves transfer of class A shares to majority shareholder
Published on 06/11/2026 at 20:27, 5 hours 26 minutes ago Turkiye Garanti Bankasi A.S.: Garanti BBVA 2025 TSRS-Aligned Sustainability Report
Published on 06/11/2026 at 19:50, 6 hours 3 minutes ago GSMA Intelligence Finds Operators Could Be the Real Game-Changers of the 2026 World Cup
Published on 06/11/2026 at 19:30, 6 hours 23 minutes ago EQS-Adhoc: Tirlán Co-operative Society Limited: PROPOSED SECONDARY PLACING & DIRECTED BUYBACK
Published on 06/11/2026 at 18:47, 7 hours 6 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 06/11/2026 at 17:45, 8 hours 8 minutes ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 17 hours 8 minutes ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 17 hours 23 minutes ago Aéroports de Paris S.A - €600 million new bond issue
Published on 06/10/2026 at 18:29, 1 day 7 hours ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026